InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Patou Gary, 董事. Officer active across 2 companies, notably Xenon Pharmaceuticals Inc.. Cumulatively, 6 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €355k. History available since 17 March 2021. The latest transaction was filed on 22 November 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Patou Gary
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
3,500 股@ US$7.385.6% 占其流量Common SharesSEC:0000950170-24-130378:0
6,378 股@ US$9.8513.3% 占其流量Common SharesSEC:0000950170-23-070841:0
7,598 股@ US$41.0565.4% 占其流量Common SharesSEC:0000950170-23-070912:0
2,057 股@ US$34.326515.6% 占其流量Common SharesSEC:0001209191-22-058916:0
2,057 股@ US$3.6780.3% 占其流量Common SharesSEC:0001209191-21-069018:0
100 股@ US$19.4919.7% 占其流量Common SharesSEC:0001209191-21-038431:0
6 条申报中的 6 条
About Patou Gary
Patou Gary is a Board Member at Xenon Pharmaceuticals Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and oversight of operations. His experience and expertise in the pharmaceutical sector are valuable assets for the company.
